To translate our findings into the clinical setting, we explored the role of ALDH2 in a proof-of-principle study in HF patients in vitro (isolated vessel) and in vivo forearm blood flow (FBF; measured by venous occlusion plethysmography). This evidence concerns the gene ALDH2 and hydrops fetalis.